13F-HR filed by Vivo Capital, LLC
Vivo Capital, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-08, with 53 holding rows worth $912,764,619.
- Accession
- 0001213900-23-084732
- Filer
- CIK 1674712
- Filed
- 2023-11-08
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 53 entries on the cover page, a total value of $912,764,619 stated on the cover page (in dollars after the unit check, H1), rows summing to $912,764,619 with VALUE read as dollars as filed, 13F file number 028-17467. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GENETRON HLDGS LTD | 37186H100 | ADS | 8,124,174 | $104,570,306 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 3,203,093 | $94,523,274 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 2,606,247 | $85,406,714 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 4,249,918 | $69,273,663 | dollars as filed | |
| AVADEL PHARMACEUTICALS, PLC | 05337M104 | COMMON STOCK-FO | 4,096,428 | $42,193,208 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 2,262,200 | $40,199,294 | dollars as filed | |
| SINOVAC BIOTECH LTD | P8696W104 | SHS | 5,900,000 | $38,173,000 | dollars as filed | |
| GERON CORP | 374163103 | COM | 16,524,634 | $35,032,224 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 6,657,992 | $33,489,700 | dollars as filed | |
| GRACELL BIOTECHNOLOGIES INC | 38406L103 | ADR | 10,881,144 | $31,337,695 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 1,678,207 | $25,743,695 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 1,873,704 | $23,140,244 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 2,244,941 | $21,888,175 | dollars as filed | |
| ALX ONCOLOGY HOLDINGS INC | 00166B105 | COMMON STOCK | 4,220,048 | $20,256,230 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 503,565 | $18,067,912 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 422,075 | $14,658,665 | dollars as filed | |
| RAYZEBIO INC | 75525N107 | COM | 633,576 | $14,065,387 | dollars as filed | |
| ICOSAVAX INC | 45114M109 | COM | 1,704,568 | $13,210,402 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,681,199 | $12,541,745 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,538,461 | $12,507,688 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 1,608,000 | $11,899,200 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 454,606 | $11,051,472 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 914,913 | $10,475,754 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 350,000 | $10,409,000 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,035,136 | $9,274,819 | dollars as filed | |
| IO BIOTECH INC | 449778109 | COM | 6,173,439 | $8,704,549 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 400,000 | $8,520,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 856,008 | $8,243,357 | dollars as filed | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 1,855,191 | $7,513,524 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,913,349 | $7,232,459 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 3,556,023 | $7,005,365 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 2,988,000 | $6,782,760 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 509,572 | $6,456,277 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 898,631 | $6,155,622 | dollars as filed | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 12,486,787 | $5,344,345 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 777,944 | $4,706,561 | dollars as filed | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 3,871,291 | $4,026,143 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 137,411 | $3,692,234 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 2,708,875 | $3,684,070 | dollars as filed | |
| SERA PROGNOSTICS INC | 81749D107 | CMN | 1,856,011 | $3,452,180 | dollars as filed | |
| UNICYCIVE THERAPEUTICS INC | 90466Y103 | CMN | 3,470,152 | $2,984,331 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 655,057 | $2,980,509 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 3,547,030 | $2,649,631 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 520,000 | $2,308,800 | dollars as filed | |
| CLENE INC | 185634102 | COM | 2,645,338 | $1,396,738 | dollars as filed | |
| IMPEL PHARMACEUTICALS INC | 45258K109 | CMN | 2,884,789 | $1,240,459 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 568,182 | $1,068,181 | dollars as filed | |
| BIOATLA INC | 09077B104 | COM | 534,181 | $908,108 | dollars as filed | |
| CODEXIS INC | 192005106 | COM | 388,144 | $733,592 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 484,439 | $639,459 | dollars as filed | |
| AMYRIS INC | 03236M200 | COM NEW | 7,750,828 | $465,050 | dollars as filed | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 370,068 | $432,980 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P108 | COM | 140,255 | $47,869 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-23-084732 | this filing | 2023-11-08 | acceptance time not in the bulk data set |